What is the mg/kg dosage of omeprazole (proton pump inhibitor) for pediatric patients?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 22, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Pediatric Omeprazole Dosing Guidelines

The recommended dosage of omeprazole for pediatric patients is weight-based: 0.7-3.3 mg/kg/day, with specific FDA-approved dosing of 10 mg daily for children weighing 10 to <20 kg and 20 mg daily for children ≥20 kg aged 2-16 years. 1, 2

FDA-Approved Dosing by Weight and Indication

  • For treatment of symptomatic GERD in children 2-16 years:

    • 10 mg once daily for children weighing 10 to <20 kg 2, 1
    • 20 mg once daily for children weighing ≥20 kg 2, 1
  • For treatment of erosive esophagitis due to acid-mediated GERD in children 2-16 years:

    • 10 mg once daily for children weighing 10 to <20 kg 2, 1
    • 20 mg once daily for children weighing ≥20 kg 2, 1

Dosing for Special Conditions

  • For eosinophilic esophagitis in children:

    • Initial treatment: 1 mg/kg twice daily (maximum 40 mg twice daily) 3, 2
    • Maintenance therapy: 1 mg/kg/day (maximum 40 mg/day) 2
  • For severe or refractory GERD:

    • Starting dose: 0.7 mg/kg/day 2, 4
    • Dose may be escalated up to 1.4-2.8 mg/kg/day in divided doses if needed 2, 4
  • For infants under 2 years with severe GERD (off-label use):

    • Starting dose: 0.7 mg/kg/day 2, 4
    • May require dose titration based on clinical response 4

Dosing Based on Clinical Evidence

  • Clinical studies have shown effectiveness with dosages ranging from 0.7-3.3 mg/kg/day (mean 1.9 mg/kg/day) for treatment of severe reflux esophagitis in children 4

  • For children with severe esophagitis who failed treatment with H2-receptor antagonists, effective dosing has been:

    • 20 mg daily for children <30 kg 5
    • 40 mg daily for children ≥30 kg 5

Administration Instructions

  • Omeprazole should be taken before meals 1
  • For children unable to swallow capsules:
    • Open the capsule and mix pellets with one tablespoon of applesauce 1, 2
    • Ensure the applesauce is not hot 1
    • Have the child swallow the mixture immediately without chewing 1
    • Follow with a glass of cool water 1
    • Do not save the mixture for future use 1

Treatment Duration

  • For symptomatic GERD: Up to 4 weeks 1
  • For erosive esophagitis: 4-8 weeks 1
  • For maintenance of healing of erosive esophagitis: Controlled studies do not extend beyond 12 months 1

Monitoring and Safety Considerations

  • Monitor for potential side effects including headaches, diarrhea, and nausea 2
  • Long-term use (>2.5 years) may be associated with enterochromaffin cell hyperplasia in up to 50% of children 2, 6

Clinical Pearls

  • Omeprazole has demonstrated superior efficacy compared to H2-receptor antagonists for pediatric GERD 2, 6
  • For critically ill pediatric patients requiring stress ulcer prophylaxis, nasogastric administration of omeprazole suspension has shown variable efficacy, with some patients requiring significant dose adjustments or not responding at all 7
  • Suspension formulation (2 mg/ml prepared with sodium bicarbonate) shows comparable blood levels to granule formulation in pediatric patients 8

References

Guideline

Pediatric Omeprazole Dosing Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Omeprazole for severe reflux esophagitis in children.

Journal of pediatric gastroenterology and nutrition, 1997

Guideline

Gastroesophageal Reflux Disease Management in Pediatric Patients

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Failure of nasogastric omeprazole suspension in pediatric intensive care patients.

Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies, 2005

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.